☆ 4.7 Letter

Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Get Full Text
Add to Collection

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 137, Issue 4, Pages 951-954

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2016.10.044

Keywords

-

Categories

Dermatology

Funding

  1. NIH [K08-CA191019]
  2. American Cancer Society [IRG 58-012-58]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.